Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tectonic Therapeutic, Inc.

TECX Clue Score49
United States Fiscal year ends December CIK 0001681087 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Alise Reicin
26 Oct 2026
Chief Executive Officer
Exercised, kept
10,000
$2.38
$23.80K
Marc Schwabish
10 Feb 2026
Chief Business Officer
Exercised, kept
4,500
$2.38
$10.71K
Alise Reicin
31 Dec 2025
Chief Executive Officer
Exercised, kept
10,966
$2.38
$26.10K
Peter McNamara
22 Dec 2025
Chief Scientific Officer
Exercised, kept
7,000
$2.98
$20.86K
Marc Schwabish
28 Jan 2025
Chief Business Officer
Exercised, kept
2,700
$2.38
$6.43K
Marc Schwabish
9 Dec 2024
Chief Business Officer
Exercised, kept
2,000
$2.38
$4.76K
Peter McNamara
3 Dec 2024
Chief Scientific Officer
Exercised, kept
3,500
$2.38
$8.33K
Geoffrey Mackay
24 Jan 2023
President & CEO
Exercised, kept
45,999
$0.91
$41.86K
Geoffrey Mackay
23 Dec 2022
President & CEO
Exercised, kept
142,013
$0.41
$58.68K
Geoffrey Mackay
24 Dec 2020
President & CEO
Exercised, kept
100,000
$0.41
$41.32K
Nerissa Kreher
8 Oct 2018
Chief Medical Officer
Exercised, kept
2,942
$0.91
$2.68K
Katina Dorton
8 Oct 2018
Chief Financial Officer
Exercised, kept
10,000
$0.91
$9.10K

What was left out

Form 4 filings counted 184
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 6
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 12
Transactions with no price 0
Shares from compensation/vesting 32,689,931
Sales filed before the plan box existed 11
History held since 22 Jun 2018